A 5-panel drug test is one of the most widely used screening tools in workplace settings — used by employers to screen job candidates and employees for illicit substance use, and available in both laboratory-processed and point-of-care (POCT) formats for in-clinic or on-site use. This guide covers how these tests work, factors that affect their accuracy, and best practices for administering them correctly.
The 5-panel test screens for the five substances in the SAMHSA-5 (Substance Abuse and Mental Health Services Administration) standard panel:
- Amphetamines
- Cocaine
- Marijuana (THC)
- Opiates
- Phencyclidine (PCP)
This test cannot detect substances outside this panel — including methadone or benzodiazepines. For broader coverage, a 10- or 25-drug testing kit is required.
5-panel tests are popular in employer and clinical settings due to their affordability, accuracy, and ease of use. They can use either urine or saliva as the specimen. Urine testing detects use from 1 to 14 days prior (or longer depending on the substance); saliva testing offers a shorter detection window of approximately 12 to 24 hours and is better suited for assessing recent or current impairment.
How Accurate Are 5-Panel Drug Tests?
Both POCT and laboratory-processed tests typically claim 99.9% accuracy — and this is technically accurate for properly administered tests. However, only laboratory-processed tests can approach true 100% accuracy, because laboratories have more advanced analytical technology and eliminate many of the variables that affect point-of-care results.
Factors that can reduce the accuracy of POCT or at-home tests include:
- Test not performed within the correct time frame after specimen collection
- Incorrect handling or administration technique
- Improper storage of the testing kit prior to use
- Use of an expired testing kit
- Subject consumed food or beverages before the test that interfere with results
- Subject took medications before the test that interfere with results
- Specimen or test tampering
For these reasons, POCT tests used in employer or clinical settings require strict protocol adherence to achieve the accuracy that laboratory processing provides automatically. Unlike at-home use, workplace and clinical POCT settings can control many of these variables — which is why many employers choose POCT tests for random employee screening while relying on lab confirmation for positive results.
Best Practices for Improving POCT Test Accuracy
For administrators conducting POCT drug tests in workplace or clinical settings, the following protocols support the most accurate results:
- Verify testing kits are stored correctly and within their expiration date before use
- Follow manufacturer instructions precisely for specimen collection, handling, and timing
- Instruct subjects to avoid food and beverages for at least two hours before specimen collection
- Instruct subjects to avoid caffeine, alcohol, nicotine, and other substances that may interfere with results
- Ensure testing environment is clean, controlled, and consistent across subjects
- Document the chain of custody for all specimens to support defensible results
What to Do if a Result Appears Inaccurate
Even with correct administration, POCT tests cannot achieve the same certainty as laboratory processing. If a result appears inconsistent with other clinical information or the subject contests it, the appropriate next step is laboratory confirmation — sending the specimen to a certified lab for analysis. Laboratory testing provides a complete breakdown of substances detected, significantly reduces false positives, and produces a defensible result suitable for employment or legal purposes.
Sourcing Drug Testing Kits
National Medical Resources, Inc. supplies 5-panel and multi-panel drug testing kits to medical offices, clinics, wellness centers, and employers. To learn more about our drug screening products, visit nmrmeds.com/drug-screening/ or contact us at nmrmeds.com/contact-us/.
MEDICAL & LEGAL DISCLAIMER
The information contained in this article is intended for licensed healthcare providers, qualified medical professionals, and workplace administrators responsible for drug testing programs. It is provided for general informational and educational purposes and does not constitute medical advice, clinical guidance, or legal counsel.
Nothing in this article should be construed as a recommendation to diagnose, treat, cure, or prevent any disease or medical condition, nor as guidance on prescribing or administering any pharmaceutical compound to any specific patient. All clinical decisions should be made by a licensed healthcare provider.
COMPOUNDED MEDICATION DISCLOSURE: Compounded medications, including compounded semaglutide and tirzepatide, are not FDA-approved drugs and have not been evaluated by the U.S. Food and Drug Administration for safety, effectiveness, or quality. Compounded drugs are not generic versions of, and are not the same as or equivalent to, FDA-approved products such as Wegovy®, Ozempic®, Zepbound®, or Mounjaro®. Compounded semaglutide and tirzepatide may only be dispensed pursuant to a valid, patient-specific prescription issued by a licensed prescriber.
The regulatory landscape governing compounded medications is subject to change. Readers are strongly encouraged to consult with a qualified healthcare regulatory attorney and to monitor updates from the U.S. Food and Drug Administration (FDA) and applicable state pharmacy boards.
National Medical Resources, Inc. (NMR Meds) is a distributor of medical and wellness products to licensed healthcare providers. NMR Meds does not provide medical advice, clinical consultation, or legal guidance.
© 2026 National Medical Resources, Inc. All rights reserved. This content is intended for licensed healthcare professionals and authorized workplace testing administrators and may not be reproduced or redistributed without written permission.